The study will be randomized controlled trial and will conducted in Shokat Khanam hospital and Anmol cancer hospital. Non-probability convenience sampling technique will be used and 48 participants will be recruited in study after randomization. The subjects will be divided into two group. Group A will receive myofascial release. Group B will receive myofascial release with resisted deep breathing. Both Group will receive Baseline treatment which is including transcutaneous electrical nerve stimulation. The total duration of treatment will be 12 weeks and there will be 2 sessions each week. The tools that will be used are Numeric Pain Rating Scale (NPRS) for pain, Circumferential limb measurements for chest mobility or lymph edema and Spirometer for respiratory efficiency. After data collection will be analyzed by using SPSS version 21.
Age
45–64
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Radiation therapy and chemotherapy was finished at least three months
6 months after mastectomy for breast cancer being diagnosed without lymphedema or with stage 1 lymphedema
Complete unilateral Mastectomy
pain and having one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the limited shoulder range of motion.
You may not be if
Presence of shoulder pathologies for which surgical indications exist
Musculoskeletal injury in adjacent areas (shoulder or neck etc.)
bilateral surgery for the treatment of breast cancer
Bilateral lymphadenectomy
Open wounds on upper limbs
Circulatory disorders
History of shoulder surgery for reasons other than breast cancer.
Clareo Health | Effect of Resisted Deep Breathing and Myofascial Release in Postmastectomy
